Most cited papers from USC Norris Comprehensive Cancer Center
What are the most cited papers from USC Norris Comprehensive Cancer Center?
The most cited paper from USC Norris Comprehensive Cancer Center is "An integrated encyclopedia of DNA elements in the human genome" (Ian Dunham et al., 2012), with 19,751 citations. Next come "Comprehensive molecular characterization of gastric adenocarcinoma" (6,680) and "The fundamental role of epigenetic events in cancer" (5,697).
Showing 50 of 60 papers. Every paper with more than 696 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | An integrated encyclopedia of DNA elements in the human genome Ian Dunham et al. · Nature | Sep 2012 | 19,751 |
| 2 | Comprehensive molecular characterization of gastric adenocarcinoma Adam Joel Bass et al. · Nature | 23 Jul 2014 | 6,680 |
| 3 | The fundamental role of epigenetic events in cancer Peter Anthony Jones, Stephen B. Baylin · Nature Reviews Genetics | Jun 2002 | 5,697 |
| 4 | The Epigenomics of Cancer Peter Anthony Jones, Stephen B. Baylin · Cell | Feb 2007 | 4,489 |
| 5 | Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial Anthony B. El-Khoueiry et al. · The Lancet | 20 Apr 2017 | 4,384 |
| 6 | Colorectal cancer statistics, 2017 Rebecca L. Siegel, Kimberly D. Miller, Stacey A. Fedewa et al. · CA A Cancer Journal for Clinicians | Mar 2017 | 3,879 |
| 7 | Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients John P. Stein, Gary Lieskovsky, Rick Cote et al. · Journal of Clinical Oncology | Feb 2001 | 3,563 |
| 8 | Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma Joaquim Bellmunt, Ronald de Wit, David J. Vaughn et al. · New England Journal of Medicine | 17 Feb 2017 | 3,457 |
| 9 | Epigenetics in human disease and prospects for epigenetic therapy Gerda Egger, Gangning Liang, Ana Maria Aparicio et al. · Nature | May 2004 | 3,245 |
| 10 | Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study Michael James Overman, Ray McDermott, Joseph L. Leach et al. · The Lancet Oncology | 19 Jul 2017 | 2,883 |
| 11 | Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Stephen J. Sawcer et al. · Nature | Aug 2011 | 2,772 |
| 12 | Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Daniel J. Klionsky et al. · Autophagy | 2 Jan 2021 | 2,743 |
| 13 | American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography Debbie Saslow, Carla Boetes, Wylie Burke et al. · CA A Cancer Journal for Clinicians | Mar 2007 | 2,657 |
| 14 | Epigenetics in cancer Shilpa Sharma, T. K. Kelly, Peter A. Jones · Carcinogenesis | 13 Sep 2009 | 2,613 |
| 15 | Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma Ghassan K. Abou‐Alfa et al. · New England Journal of Medicine | 4 Jul 2018 | 2,386 |
| 16 | Cancer-epigenetics comes of age Peter A. Jones, Peter W. Laird · Nature Genetics | Feb 1999 | 2,361 |
| 17 | ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia Stephen G. Landt et al. · Genome Research | Sep 2012 | 2,270 |
| 18 | The Role of DNA Methylation in Mammalian Epigenetics Peter Anthony Jones, Daiya Takai · Science | 10 Aug 2001 | 2,140 |
| 19 | CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer Daniel J. Weisenberger et al. · Nature Genetics | 25 Jun 2006 | 1,999 |
| 20 | Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases Suzanne Marie Garland, Mauricio Hernández‐Ávila, Cosette Marie Wheeler et al. · New England Journal of Medicine | 9 May 2007 | 1,907 |
| 21 | Non-homologous DNA end joining and alternative pathways to double-strand break repair Howard H. Chang, Nicholas R. Pannunzio, Noritaka Adachi et al. · Nature Reviews Molecular Cell Biology | 17 May 2017 | 1,815 |
| 22 | Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials Robert Charles Doebele et al. · The Lancet Oncology | 11 Dec 2019 | 1,802 |
| 23 | CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy Ryuma Tokunaga, Wu Zhang, Madiha Naseem et al. · Cancer Treatment Reviews | 26 Nov 2017 | 1,718 |
| 24 | The power and the promise of DNA methylation markers Peter W. Laird · Nature reviews. Cancer | Apr 2003 | 1,581 |
| 25 | Architecture of the human regulatory network derived from ENCODE data Mark Gerstein et al. · Nature | Sep 2012 | 1,564 |
| 26 | Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update Nigel S. Key, Alok A. Khorana, Nicole M. Kuderer et al. · Journal of Clinical Oncology | 5 Aug 2019 | 1,517 |
| 27 | Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer Robert J. Mayer et al. · New England Journal of Medicine | 13 May 2015 | 1,457 |
| 28 | MethyLight: a high-throughput assay to measure DNA methylation Cindy A. Eads · Nucleic Acids Research | 15 Apr 2000 | 1,452 |
| 29 | Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells Yoshimasa Saito, Gangning Liang, Gerda Egger et al. · Cancer Cell | Jun 2006 | 1,334 |
| 30 | Epigenetic therapy of cancer: past, present and future Christine B. Yoo, Peter Anthony Jones · Nature Reviews Drug Discovery | 2006 | 1,299 |
| 31 | COBRA: a sensitive and quantitative DNA methylation assay Zhongguo Xiong, Peter W. Laird · Nucleic Acids Research | Jun 1997 | 1,195 |
| 32 | Hairpin Opening and Overhang Processing by an Artemis/DNA-Dependent Protein Kinase Complex in Nonhomologous End Joining and V(D)J Recombination Yunmei Ma, Ulrich Pannicke, Klaus Schwarz et al. · Cell | Mar 2002 | 1,171 |
| 33 | Cancer Genetics and Epigenetics: Two Sides of the Same Coin? Jueng Soo You, Peter Anthony Jones · Cancer Cell | Jul 2012 | 1,169 |
| 34 | Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients Peter P. Lee, Cassian Yee, Peter Aidan Savage et al. · Nature Medicine | Jun 1999 | 1,126 |
| 35 | Comprehensive functional genomic resource and integrative model for the human brain Daifeng Wang et al. · Science | 13 Dec 2018 | 1,106 |
| 36 | Can we safely target the WNT pathway? Michaël Kahn · Nature Reviews Drug Discovery | Jul 2014 | 1,060 |
| 37 | The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress Amy Shiu Lee · Methods | Mar 2005 | 1,004 |
| 38 | Mechanism and regulation of human non-homologous DNA end-joining Michael R. Lieber, Yunmei Ma, Ulrich Pannicke et al. · Nature Reviews Molecular Cell Biology | Sep 2003 | 975 |
| 39 | Epidemiology of nasopharyngeal carcinoma Mimi C. Yu, Jian‐Min Yuan · Seminars in Cancer Biology | Dec 2002 | 946 |
| 40 | The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions Hamid Bolouri et al. · Nature Medicine | 11 Dec 2017 | 900 |
| 41 | Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples David Sidransky, Andrew von Eschenbach, Yvonne Tsai et al. · Science | 3 May 1991 | 896 |
| 42 | Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma Sapna Pradyuman Patel et al. · New England Journal of Medicine | Mar 2023 | 893 |
| 43 | The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors Keith D. Robertson, É. Uzvölgyi, Gangning Liang et al. · Nucleic Acids Research | 1999 | 856 |
| 44 | Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials Dirk Arnold, Beranger Lueza, Jean-Yves Douillard et al. · Annals of Oncology | 5 Apr 2017 | 853 |
| 45 | Hormonal carcinogenesis Brian E. Henderson, Heather Spencer Feigelson · Carcinogenesis | Mar 2000 | 831 |
| 46 | Accumulation of Nuclear p53 and Tumor Progression in Bladder Cancer David Esrig, Donald A. Elmajian, Susan G. Groshen et al. · New England Journal of Medicine | 10 Nov 1994 | 809 |
| 47 | Epigenetic modifications as therapeutic targets Theresa Kathleen Kelly, Daniel Diniz De Carvalho, Peter Anthony Jones · Nature Biotechnology | Oct 2010 | 805 |
| 48 | HER kinase inhibition in patients with HER2- and HER3-mutant cancers David Michael Hyman et al. · Nature | 31 Jan 2018 | 796 |
| 49 | Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma Toni K. Choueiri et al. · New England Journal of Medicine | 18 Aug 2021 | 792 |
| 50 | A clinical prototype for active microwave imaging of the breast Keith D. Paulsen, Steven P. Poplack, Dun Li et al. · IEEE Transactions on Microwave Theory and Techniques | 2000 | 779 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.